The usual MO of this company is late announcements so don't hold your breath on one coming in March. Let's just hope it isn't an embarrassment like the Telethon partnership, whatever that was supposed to be.
Perhaps the best indication on the quality in the new leadership will be if they can bring out something important in the time frame promised.
- Forums
- ASX - By Stock
- FGL
- How WGL Generates Revenue
How WGL Generates Revenue, page-272
Featured News
Add FGL (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.921M |
Open | High | Low | Value | Volume |
4.6¢ | 4.7¢ | 4.0¢ | $22.72K | 543.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 600 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.7¢ | 668 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 600 | 0.042 |
1 | 8600 | 0.041 |
1 | 25000 | 0.038 |
1 | 100000 | 0.034 |
1 | 93781 | 0.031 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 668 | 1 |
0.048 | 17614 | 1 |
0.110 | 52515 | 1 |
0.120 | 200271 | 2 |
0.125 | 26627 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
FGL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online